Skip to main content
    I

    Innoviva Inc (INVA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $18.30
    -0.19 (-1.03%)

    Market Cap: $1.31B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Innoviva Inc (INVA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Innoviva (INVA) has a market cap of $1.31B and an enterprise value of $991.73M. It kept 44.13% of revenue as net income over the last 12 months. Its trailing P/E of 5.2x is below its 10-year median of 9.1x.

    Total Valuation

    Enterprise value is 24.54% below the market cap, as cash exceeds debt.

    Market Cap$1.31B
    Enterprise Value$991.73M
    Latest price (Nov 17, 2026)$18.30

    Key Dates

    The next earnings report is expected on Feb 23, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 23, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 1.84% in the quarter ended Sep 30, 2026 and grew 7.32% a year over 2 years.

    Shares Outstanding72.07M
    Shares Change (YoY)+4.36%
    Shares Change (QoQ)-1.84%
    Share Count Growth (2Y CAGR)+7.32%

    Valuation Ratios

    Sales and book value multiples are 3.0x and 1.2x. Its year-end P/E ranged from 6.2x to 59.8x from 2016 to 2025.

    P/E Ratio5.2x
    Forward P/E12.3x
    P/S Ratio3.0x
    Forward P/S3.0x
    P/B Ratio1.2x
    P/TBV Ratio1.4x
    P/FCF Ratio7.2x
    P/OCF Ratio7.2x
    PEG Ratio0.4

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 4.6x EBITDA and 5.5x free cash flow.

    EV / Earnings5.1x
    EV / Sales2.3x
    EV / EBITDA4.6x
    EV / FCF5.5x

    Price Statistics

    The stock is down 17.75% over 52 weeks and trades 11.08% below its 50-day average.

    Beta (1Y)0.34
    52-Week Change-17.75%
    1-Month Change-13.19%
    3-Month Change-14.80%
    6-Month Change-15.78%
    5-Year Change+21.60%
    10-Year Change+106.02%
    Total Return (1Y)-17.75%
    Total Return (3Y CAGR)+10.08%
    Total Return (5Y CAGR)+1.33%
    Return vs SPY (1Y)-27.88%
    Max Drawdown (1Y)-24.50%
    Max Drawdown (3Y)-24.50%
    Sharpe Ratio (1Y)-0.70
    Correlation with SPY (1Y)0.18
    50-Day Average$20.58
    200-Day Average$21.87
    52-Week Range$18.41 to $25.15
    RSI (14 Days)27.3
    Average Volume (20 Days)897.36K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 15.44x current liabilities, and total debt is 0.23x shareholder equity.

    Current Ratio15.44x
    Quick Ratio14.58x
    Debt / Equity0.23x
    Debt / EBITDA1.20x
    Debt / FCF1.42x
    Interest Coverage8.85x

    Returns and Efficiency

    Return on invested capital is 10.78% over the last 12 months, against a 5-year average of 19.14%.

    Return on Equity (ROE)17.01%
    Return on Assets (ROA)12.58%
    Return on Invested Capital (ROIC)10.78%
    ROE (5Y Average)36.20%
    ROA (5Y Average)18.11%
    ROIC (5Y Average)19.14%
    Asset Turnover0.30x
    Inventory Turnover2.73x
    Receivables Turnover9.24x
    Cash Conversion Cycle156 days

    Taxes

    Income tax took 13.63% of pretax income over the last 12 months.

    Income Tax (TTM)$30.53M
    Effective Tax Rate13.63%

    Scores

    INVA has an Altman Z-Score of 3.47, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score3.47
    Altman Z ZoneSafe
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $438.32M over the last 12 months is up 12.82% from the 12 months before.

    Revenue$438.32M
    Revenue Growth (YoY)+12.82%
    Gross Profit$326.50M
    Operating Income$170.15M
    Pretax Income$223.97M
    Net Income$193.44M
    Reported EPS (TTM)$3.50

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 74.03% of the $1.54B in total assets.

    Cash and Equivalents$581.39M
    Total Debt$258.82M
    Net Cash$322.57M
    Net Cash Per Share$4.48
    Working Capital$722.22M
    Shareholder Equity$1.14B
    Book Value Per Share$15.78
    Tangible Book Value$957.34M
    Tangible Book Per Share$13.28
    Total Assets$1.54B
    Total Liabilities$400.41M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $955.00K of capital spending, operating cash flow left $182.51M of free cash flow.

    Operating Cash Flow$183.47M
    Capital Expenditures$955.00K
    Free Cash Flow$182.51M
    FCF Per Share$2.53
    Depreciation and Amortization$41.99M
    Share Repurchases$81.92M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 38.82%, against a 5-year average of 67.73%.

    Gross Margin74.49%
    Operating Margin38.82%
    Pretax Margin51.10%
    Net Margin44.13%
    FCF Margin41.64%
    Gross Margin (5Y Average)86.49%
    Operating Margin (5Y Average)67.73%
    Net Margin (5Y Average)58.19%

    Growth

    Revenue grew 7.47% a year over 3 years, and EPS 70.09% a year.

    Revenue Growth (3Y CAGR)+7.47%
    Revenue Growth (5Y CAGR)+4.08%
    EPS Growth (3Y CAGR)+70.09%
    EPS Growth (5Y CAGR)+11.63%
    FCF Growth (3Y CAGR)-0.98%
    FCF Growth (5Y CAGR)-8.96%
    Operating Income Growth (3Y CAGR)-20.05%
    Book Value Per Share Growth (2Y CAGR)+31.61%
    Tangible Book Per Share Growth (2Y CAGR)+50.75%

    Revenue and profit by year

    Dividends and Yields

    INVA does not pay a dividend. Its free cash flow yield is 13.84%.

    Earnings Yield19.23%
    FCF Yield13.84%
    Buyback Yield5.93%
    Shareholder Yield5.93%

    Peer Position

    Against 9 similar companies, INVA has the 9th highest P/S.

    P/S Ratio3.0x vs 8.4x median
    ROIC10.78% vs -66.62% median
    Revenue Growth (Trailing 4 Quarters, YoY)+12.82% vs +13.52% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 7.50% and EPS growth at -16.21% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+7.50%
    EPS Growth Forecast (2Y CAGR)-16.21%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About INVA

    What is INVA's market cap?

    Innoviva has a market cap of $1.31B. Its enterprise value, which adds debt and subtracts cash, is $991.73M.

    What is INVA's P/E ratio?

    Innoviva has a trailing P/E ratio of 5.2x and a forward P/E of 12.3x.

    How many shares of INVA are outstanding?

    Innoviva has 72.07M shares outstanding. The count is up 4.36% from a year earlier.

    Does INVA pay a dividend?

    No. Innoviva does not pay a dividend.

    How much debt does INVA have?

    Innoviva has $258.82M of total debt and $581.39M of cash and equivalents, a net cash position of $322.57M.